Crizanlizumab

Last Updated: 04/28/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 144 publications

Rethinking Sickle Cell Disease as a Systemic Vasculopathy.

Rethinking Sickle Cell Disease as a Systemic Vasculopathy.

Journal: Cells

Published: January 02, 2026

Optimizing the right time to start sickle cell therapies.

Optimizing the right time to start sickle cell therapies.

Journal: Hematology. American Society of Hematology. Education Program

Published: December 05, 2025

Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US.

Adherence, treatment utilization, clinical and economic outcomes of patients with sickle cell disease with recurrent vaso-occlusive crises treated with recently approved chronic therapies in the US.

Journal: Journal of comparative effectiveness research

Published: November 24, 2025

The Role of Pediatric Clinicians in the Diagnosis, Management, and Referral of Priapism in Children and Adolescents with Sickle Cell Disease.

The Role of Pediatric Clinicians in the Diagnosis, Management, and Referral of Priapism in Children and Adolescents with Sickle Cell Disease.

Journal: Pediatric clinics of North America

Published: November 09, 2025

Low Use of FDA-Approved Medications for Sickle Cell Disease in Adults.

Low Use of FDA-Approved Medications for Sickle Cell Disease in Adults.

Journal: European journal of haematology

Published: October 23, 2025

Emerging Therapies for Sickle Cell Disease: From Symptom Management to Curative Gene Therapy.

Emerging Therapies for Sickle Cell Disease: From Symptom Management to Curative Gene Therapy.

Journal: Cureus

Published: October 21, 2025

Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice.

Spleen Tyrosine Kinase Inhibition Mitigates Hemin-Induced Thromboinflammation in an Organ-Specific Manner in Sickle Cell Mice.

Journal: Arteriosclerosis, thrombosis, and vascular biology

Published: August 15, 2025

Curative Therapies for Hemophilias and Hemoglobinopathies in Adults: Immune, Gene, and Stem Cell Approaches in a Global Context.

Curative Therapies for Hemophilias and Hemoglobinopathies in Adults: Immune, Gene, and Stem Cell Approaches in a Global Context.

Journal: Biomedicines

Published: July 06, 2025

Advancing Sickle Cell Disease Treatment in Sub-Saharan Africa: Challenges and Opportunities for Disease Modifying Therapies.

Advancing Sickle Cell Disease Treatment in Sub-Saharan Africa: Challenges and Opportunities for Disease Modifying Therapies.

Journal: American journal of hematology

Published: June 02, 2025

Now where do we STAND with crizanlizumab?

Now where do we STAND with crizanlizumab?

Journal: The Lancet. Haematology

Published: February 03, 2025

Low bone mineral density and pain impact in adults with sickle cell disease.

Low bone mineral density and pain impact in adults with sickle cell disease.

Journal: Blood advances

Published: January 21, 2025

Grandchildren of GRNDaD: Shifts in disease-modifying therapy at the adolescent transition in sickle cell disease.

Grandchildren of GRNDaD: Shifts in disease-modifying therapy at the adolescent transition in sickle cell disease.

Journal: British journal of haematology

Published: January 20, 2025

Showing 1-12 of 144

Last Updated: 04/28/2026